Literature DB >> 8861308

Radiosurgery: a minimally interventional alternative to microsurgery in the management of acoustic neuroma.

D M Forster1, A A Kemeny, A Pathak, L Walton.   

Abstract

We report the results of treatment with radiosurgery of 29 tumours in 27 patients with acoustic neuromas between 1986 and 1989. The median follow-up was 6.6 years. The treatment appears to be an effective alternative to surgery for patients with tumours of 3 cm diameter or less. The mortality and morbidity of the treatment and the presentation of cranial nerve function is comparable to the very best surgical results. Every patient with an acoustic neuroma should be informed about this alternative to direct surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8861308     DOI: 10.1080/02688699650040322

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  5 in total

1.  Radiosurgery for brain tumours. Editorial was wrong to denigrate radiosurgery so strongly.

Authors:  C B Adams
Journal:  BMJ       Date:  1999-05-29

2.  Long-term outcome of gamma knife radiosurgery for vestibular schwannoma.

Authors:  Shyamal C Bir; Sudheer Ambekar; Papireddy Bollam; Anil Nanda
Journal:  J Neurol Surg B Skull Base       Date:  2014-04-17

3.  Therapeutic profile of single-fraction radiosurgery of vestibular schwannoma: unrelated malignancy predicts tumor control.

Authors:  Berndt Wowra; Alexander Muacevic; Christoph Fürweger; Christian Schichor; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2012-05-03       Impact factor: 12.300

4.  Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas.

Authors:  J G Rowe; M W R Radatz; L Walton; A Hampshire; S Seaman; A A Kemeny
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 5.  Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view.

Authors:  Jan Vesper; B Bölke; C Wille; P A Gerber; C Matuschek; M Peiper; H J Steiger; W Budach; G Lammering
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.